Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123876224 | 12387622 | 4 | F | 201209 | 20160909 | 20160520 | 20160915 | EXP | CA-ROCHE-1758782 | ROCHE | 46.21 | YR | M | Y | 0.00000 | 20160915 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123876224 | 12387622 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 300 MG EVERY 4 WEEKS | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | 300 | MG | SOLUTION FOR INJECTION | |||||
123876224 | 12387622 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 10 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 11 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 12 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 13 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 14 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 15 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 16 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 17 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 18 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 19 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 20 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 21 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 22 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0060A,S0068B,S0001E,S0041 | 103976 | SOLUTION FOR INJECTION | |||||||
123876224 | 12387622 | 23 | C | ALVESCO | CICLESONIDE | 1 | Unknown | U | 0 | ||||||||||
123876224 | 12387622 | 24 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
123876224 | 12387622 | 25 | C | BUDESONIDE. | BUDESONIDE | 1 | Unknown | U | 0 | ||||||||||
123876224 | 12387622 | 26 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | U | 0 | ||||||||||
123876224 | 12387622 | 27 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | TAKES IT ALL THE TIME | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123876224 | 12387622 | 1 | Asthma |
123876224 | 12387622 | 23 | Product used for unknown indication |
123876224 | 12387622 | 24 | Product used for unknown indication |
123876224 | 12387622 | 25 | Product used for unknown indication |
123876224 | 12387622 | 26 | Product used for unknown indication |
123876224 | 12387622 | 27 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123876224 | 12387622 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123876224 | 12387622 | Back pain | |
123876224 | 12387622 | Blood pressure increased | |
123876224 | 12387622 | Cough | |
123876224 | 12387622 | Drug ineffective | |
123876224 | 12387622 | Dyspnoea | |
123876224 | 12387622 | Hypoventilation | |
123876224 | 12387622 | Nasal congestion | |
123876224 | 12387622 | Nasopharyngitis | |
123876224 | 12387622 | Post-traumatic neck syndrome | |
123876224 | 12387622 | Productive cough | |
123876224 | 12387622 | Rales | |
123876224 | 12387622 | Rhinorrhoea | |
123876224 | 12387622 | Road traffic accident | |
123876224 | 12387622 | Sinusitis | |
123876224 | 12387622 | Sputum discoloured | |
123876224 | 12387622 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123876224 | 12387622 | 1 | 20120604 | 0 | ||
123876224 | 12387622 | 2 | 20130924 | 0 | ||
123876224 | 12387622 | 3 | 20131023 | 0 | ||
123876224 | 12387622 | 4 | 20140212 | 0 | ||
123876224 | 12387622 | 5 | 20140312 | 0 | ||
123876224 | 12387622 | 6 | 20140508 | 0 | ||
123876224 | 12387622 | 7 | 20140702 | 0 | ||
123876224 | 12387622 | 8 | 20140730 | 0 | ||
123876224 | 12387622 | 9 | 20140827 | 0 | ||
123876224 | 12387622 | 10 | 20141124 | 0 | ||
123876224 | 12387622 | 11 | 20150318 | 0 | ||
123876224 | 12387622 | 12 | 20150901 | 0 | ||
123876224 | 12387622 | 13 | 20151026 | 0 | ||
123876224 | 12387622 | 14 | 20151125 | 0 | ||
123876224 | 12387622 | 15 | 20151222 | 0 | ||
123876224 | 12387622 | 16 | 20160125 | 0 | ||
123876224 | 12387622 | 17 | 20160316 | 0 | ||
123876224 | 12387622 | 18 | 20160411 | 0 | ||
123876224 | 12387622 | 19 | 20160509 | 0 | ||
123876224 | 12387622 | 20 | 20160606 | 0 | ||
123876224 | 12387622 | 21 | 20160705 | 0 | ||
123876224 | 12387622 | 22 | 20160803 | 20160803 | 0 |